Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 664

1.

Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review.

Kim BJ, Kim JH, Kim HS, Zang DY.

Oncotarget. 2017 Feb 21;8(8):13979-13985. doi: 10.18632/oncotarget.14704. Review.

2.

The Clinicopathological Significance of Epigenetic Silencing of VHL Promoter and Renal Cell Carcinoma: A Meta-Analysis.

Yang L, Zhao Z, Zhao S, Chen C, Cong X, Li Z, Ren M.

Cell Physiol Biochem. 2016;40(6):1465-1472. doi: 10.1159/000453198. Epub 2016 Dec 20.

3.

VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease.

Mathó C, Sansó G, Diez B, Barontini M, Pennisi PA.

Genet Test Mol Biomarkers. 2016 Dec;20(12):771-776. doi: 10.1089/gtmb.2016.0204. Epub 2016 Sep 12.

PMID:
27617348
4.

pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner.

Guo J, Chakraborty AA, Liu P, Gan W, Zheng X, Inuzuka H, Wang B, Zhang J, Zhang L, Yuan M, Novak J, Cheng JQ, Toker A, Signoretti S, Zhang Q, Asara JM, Kaelin WG Jr, Wei W.

Science. 2016 Aug 26;353(6302):929-32. doi: 10.1126/science.aad5755.

5.

Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance.

Razafinjatovo C, Bihr S, Mischo A, Vogl U, Schmidinger M, Moch H, Schraml P.

BMC Cancer. 2016 Aug 17;16:638. doi: 10.1186/s12885-016-2688-0.

6.

Clinical and molecular characteristics of East Asian patients with von Hippel-Lindau syndrome.

Wong M, Chu YH, Tan HL, Bessho H, Ngeow J, Tang T, Tan MH.

Chin J Cancer. 2016 Aug 15;35(1):79. doi: 10.1186/s40880-016-0141-z.

7.

A novel VHLα isoform inhibits Warburg effect via modulation of PKM splicing.

Liu Y, Yang H, Li L, Chen S, Zuo F, Chen L.

Tumour Biol. 2016 Oct;37(10):13649-13657. Epub 2016 Jul 29.

PMID:
27473082
8.
9.

Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.

Lee JS, Lee JH, Lee KE, Kim JH, Hong JM, Ra EK, Seo SH, Lee SJ, Kim MJ, Park SS, Seong MW.

BMC Med Genet. 2016 Jul 20;17(1):48. doi: 10.1186/s12881-016-0306-2.

10.

The VHL short variant involves in protein quality control.

Liu Y, Yang H, Zuo F, Chen L.

Gene. 2016 Sep 1;589(1):63-71. doi: 10.1016/j.gene.2016.05.027. Epub 2016 May 16.

PMID:
27196060
11.

Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function.

German P, Bai S, Liu XD, Sun M, Zhou L, Kalra S, Zhang X, Minelli R, Scott KL, Mills GB, Jonasch E, Ding Z.

Oncogene. 2016 Sep 22;35(38):4973-80. doi: 10.1038/onc.2016.40. Epub 2016 Mar 14.

12.

(1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism.

Cuperlovic-Culf M, Cormier K, Touaibia M, Reyjal J, Robichaud S, Belbraouet M, Turcotte S.

Int J Cancer. 2016 May 15;138(10):2439-49. doi: 10.1002/ijc.29947. Epub 2016 Jan 29.

13.

Combined Analyses of the VHL and Hypoxia Signaling Axes in an Isogenic Pairing of Renal Clear Cell Carcinoma Cells.

Malec V, Coulson JM, Urbé S, Clague MJ.

J Proteome Res. 2015 Dec 4;14(12):5263-72. doi: 10.1021/acs.jproteome.5b00692. Epub 2015 Nov 16.

PMID:
26506913
14.

PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE.

Krzystolik K, Stopa M, Kuprjanowicz L, Drobek-Slowik M, Cybulski C, Jakubowska A, Gronwald J, Lubiński J, Lubiński W.

Retina. 2016 Feb;36(2):325-34. doi: 10.1097/IAE.0000000000000707.

PMID:
26308528
15.

Novel Homozygous Mutation of the Internal Translation Initiation Start Site of VHL is Exclusively Associated with Erythrocytosis: Indications for Distinct Functional Roles of von Hippel-Lindau Tumor Suppressor Isoforms.

Bartels M, van der Zalm MM, van Oirschot BA, Lee FS, Giles RH, Kruip MJ, Gitz-Francois JJ, Van Solinge WW, Bierings M, van Wijk R.

Hum Mutat. 2015 Nov;36(11):1039-42. doi: 10.1002/humu.22846. Epub 2015 Aug 17.

PMID:
26224408
16.

Isoform-specific interactions of the von Hippel-Lindau tumor suppressor protein.

Minervini G, Mazzotta GM, Masiero A, Sartori E, Corrà S, Potenza E, Costa R, Tosatto SC.

Sci Rep. 2015 Jul 27;5:12605. doi: 10.1038/srep12605.

17.

Integrated genomic analyses identify frequent gene fusion events and VHL inactivation in gastrointestinal stromal tumors.

Kang G, Yun H, Sun CH, Park I, Lee S, Kwon J, Do I, Hong ME, Van Vrancken M, Lee J, Park JO, Cho J, Kim KM, Sohn TS.

Oncotarget. 2016 Feb 9;7(6):6538-51. doi: 10.18632/oncotarget.3731.

18.

A novel mutation links to von Hippel-Lindau syndrome in a Chinese family with hemangioblastoma.

Fu XM, Zhao SL, Gui JC, Jiang YQ, Shen MN, Su DL, Gu BJ, Wang XQ, Ren QJ, Yin XD, Huang WB, Chen XG.

Genet Mol Res. 2015 May 4;14(2):4513-20. doi: 10.4238/2015.May.4.9.

19.

Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism.

Leisz S, Schulz K, Erb S, Oefner P, Dettmer K, Mougiakakos D, Wang E, Marincola FM, Stehle F, Seliger B.

Oncotarget. 2015 May 10;6(13):11395-406.

20.

VHL gene mutation analysis of a Chinese family with non- syndromic pheochromocytomas and patients with apparently sporadic pheochromocytoma.

Zhang B, Qian J, Chang DH, Wang YM, Zhou DH, Qiao GM.

Asian Pac J Cancer Prev. 2015;16(5):1977-80.

Supplemental Content

Support Center